Recombinant Human KCNJ10 Protein，His

KCNJ10, also known as the inwardly rectifying potassium channel 10, is a member of the KCNJ family of potassium ion channels, which are critical for maintaining potassium homeostasis and regulating cellular excitability. Mutations in the KCNJ10 gene have been linked to various disorders, particularly those affecting the brain and kidney, such as East syndrome, characterized by severe neurological features and sensorineural hearing loss. Research into the recombinant expression of KCNJ10 protein is crucial for understanding its physiological roles and the consequences of its dysfunction. By producing and characterizing recombinant KCNJ10, scientists can study the channel's biophysical properties, gating mechanisms, and interactions with regulatory proteins. This research also holds significance for the development of potential therapeutic strategies targeting KCNJ10-related diseases. The advancement of techniques such as cryo-electron microscopy and patch-clamp electrophysiology enhances our ability to elucidate the structural and functional nuances of KCNJ10, paving the way for a deeper understanding of its role in cellular signaling and disease pathology. This knowledge could contribute to the design of drugs that modulate KCNJ10 activity, offering new avenues for treatment of associated conditions.